Tasimelteon
- Generic Name
- Tasimelteon
- Brand Names
- Hetlioz
- Drug Type
- Small Molecule
- Chemical Formula
- C15H19NO2
- CAS Number
- 609799-22-6
- Unique Ingredient Identifier
- SHS4PU80D9
- Background
Tasimelteon is a selective dual melatonin receptor agonist indicated for the treatment of Non-24-Hour Sleep-Wake Disorder (N24HSWD). Occurring commonly in blind individuals without light perception, this condition is often characterized by periods of night-time insomnia and day-time sleepiness. In blind individuals, a lack of light stimulation causes an exte...
- Indication
Tasimelteon oral capsules are indicated for the treatment of non-24 hour sleep-wake disorder in adult patients and for the treatment of nighttime sleep disturbances in Smith-Magenis Syndrome in patients ≥16 years old. Tasimelteon oral suspension is indicated for the treatment of nighttime sleep disturbances in Smith-Magenis syndrome in patients 3 to 15 years...
- Associated Conditions
- Non 24 Hour Sleep Wake Disorder, Sleep Disturbance
- Associated Therapies
- -
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.